CANbridge Pharmaceuticals Inc. (HK:1228) has released an update.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
CANbridge Pharmaceuticals Inc. has announced plans to downsize its U.S. operations, including terminating its exclusive license agreement with the University of Massachusetts and negotiating the end of its Boston office lease. These steps aim to alleviate liquidity pressures without impacting the company’s overall operations or financial performance. However, CANbridge’s future as a going concern depends on securing additional financing sources.
For further insights into HK:1228 stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue